Scott Eblen to Protein Kinase Inhibitors
This is a "connection" page, showing publications Scott Eblen has written about Protein Kinase Inhibitors.
Connection Strength
0.142
-
Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways. Bioorg Med Chem Lett. 2010 Aug 01; 20(15):4526-30.
Score: 0.073
-
Structure-activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: development of potential substrate-specific ERK1/2 inhibitors. Bioorg Med Chem Lett. 2009 Nov 01; 19(21):6042-6.
Score: 0.069